收藏切换
Application of tofacitinib in treatment of seven patients with anti-MDA5 autoantibody-positive dermatomyositis-associated with interstitial lung disease and literature review
收藏切换
PDF
Hua Li1, 2, Yu-Rong Zhao1, Xiao-Fei Liu3, Si-Min Liao1, Bo Zhou1, Chun-Hua Yang1, Kun-Peng Li1, Xiao-Hu Deng1, Jiang-Lin Zhang1, Feng Huang1, Jian Zhu1, *
Medical Journal of Chinese People’s Liberation Army | 2023, 48(1) : 91 - 96
Less
收藏切换
Medical Journal of Chinese People’s Liberation Army | 2023, 48(1): 91-96
Clinical Research
Application of tofacitinib in treatment of seven patients with anti-MDA5 autoantibody-positive dermatomyositis-associated with interstitial lung disease and literature review
Full
Hua Li1, 2, Yu-Rong Zhao1, Xiao-Fei Liu3, Si-Min Liao1, Bo Zhou1, Chun-Hua Yang1, Kun-Peng Li1, Xiao-Hu Deng1, Jiang-Lin Zhang1, Feng Huang1, Jian Zhu1, *
Affiliations
  • 1Department of Rheumatology and Immunology, the First Medical Center of Chinese PLA General Hospital, Beijing 100853, China
  • 2Department of Rheumatology and Immunology, the First Hospital of Yulin, Yulin, Shaanxi 719000, China
  • 3Department of Rheumatology and Immunology, Hainan Hospital of Chinese PLA General Hospital, Sanya, Hainan 572013, China
Published: 2023-01-28 doi: 10.11855/j.issn.0577-7402.2023.01.0091
Outline
收藏切换

Objective By literature review to retrospectively study the clinical characteristics, diagnosis and treatment process, and prognosis of anti-melanoma differentiation associated gene 5 (MDA5) autoantibody-positive dermatomyositis-associated with interstitial lung disease (ILD) treated with tofacitinib (TOF), so as to improve the understanding of the disease. Methods Retrospectively analyze the clinical and laboratory characteristics, imaging findings and adverse reactions before and after TOF treatment in seven patients who admitted to the First Medical Center of Chinese PLA General Hospital from January 2018 to October 2021. Thirty-six cases were found by searching databases to summarize the efficacy and safety of TOF in treating patients with anti-MDA5 autoantibody-positive dermatomyositis-associated ILD. Results Of the 7 patients, 5 were female and 2 were male with mean age of 50(30-64) years, the mean disease duration was 3(1-36) months, and the mean follow-up time was 12(1-35) months. Of them, 4 received previously the other immunosuppressive therapy, and 3 were newly treated. One patient died, and the remaining 6 patients were in relatively stable condition and maintenance treatment. One patient experienced fungal infection in the 18th month after TOF treatment. A total of 36 cases of anti-MDA5 autoantibody-positive dermatomyositis have been reported in databases. Clinical symptoms, laboratory tests and imaging findings were all improved after TOF therapy. Opportunistic infection occurred in 9(25%) cases after application of TOF. Conclusion Application of TOF is an effective and safe regimen in treatment of anti-MDA5 autoantibody-positive dermatomyositis-associated ILD, while attention should be paid for monitoring the opportunistic infection during treatment.

dermatomyositis  /  interstitial lung disease  /  melanoma differentiation associated gene 5  /  tofacitinib
Hua Li, Yu-Rong Zhao, Xiao-Fei Liu, Si-Min Liao, Bo Zhou, Chun-Hua Yang, Kun-Peng Li, Xiao-Hu Deng, Jiang-Lin Zhang, Feng Huang, Jian Zhu. Application of tofacitinib in treatment of seven patients with anti-MDA5 autoantibody-positive dermatomyositis-associated with interstitial lung disease and literature review[J]. Medical Journal of Chinese People’s Liberation Army, 2023 , 48 (1) : 91 -96 . DOI: 10.11855/j.issn.0577-7402.2023.01.0091
Year 2023 volume 48 Issue 1
PDF
238
108
Cite this Article
BibTeX
Article Info
doi: 10.11855/j.issn.0577-7402.2023.01.0091
  • Receive Date:2022-02-07
  • Online Date:2025-12-03
  • Published:2023-01-28
Article Data
Affiliations
History
  • Received:2022-02-07
  • Accepted:2022-06-28
Affiliations
    1Department of Rheumatology and Immunology, the First Medical Center of Chinese PLA General Hospital, Beijing 100853, China
    2Department of Rheumatology and Immunology, the First Hospital of Yulin, Yulin, Shaanxi 719000, China
    3Department of Rheumatology and Immunology, Hainan Hospital of Chinese PLA General Hospital, Sanya, Hainan 572013, China

Corresponding:

References
Share
https://castjournals.cast.org.cn/joweb/jfjyxzz/EN/10.11855/j.issn.0577-7402.2023.01.0091
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT